CIK 0001721484
- Emerging growth company
Longeveron Inc.
Sign in to watch- Ticker
- LGVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472174146
- Phone
- +1 305-302-7158
- Business address
- 1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
- Former names
- LONGEVERON LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 14 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-20 | Lehr Paul T General Counsel, Secretary | Option exercise · Subscription Rights (right to buy) | −2,000 | 729,625 | ||
| 2023-09-12 | Hare Joshua Chief Scientific Officer | Option exercise | +30,000 | $3.00 | $90K | 7,823,263 |
| 2023-09-12 | Hare Joshua Chief Scientific Officer | Option exercise · Subscription Rights (right to buy) | −30,000 | 39,196,771 | ||
| 2023-09-12 | Locklear Lisa Chief Financial Officer | Other acquisition | +5,000 | $3.00 | $15K | 45,000 |
| 2023-09-12 | Locklear Lisa Chief Financial Officer | Purchase · Subscription Rights (right to buy) | +5,000 | $0.02 | $75 | 5,000 |
| 2023-09-12 | Locklear Lisa Chief Financial Officer | Other disposition · Subscription Rights (right to buy) | −5,000 | 0 | ||
| 2023-09-12 | Hashad Mohamed Wa'el Ahmed Chief Executive Officer | Option exercise | +10,000 | $3.00 | $30K | 47,566 |
| 2023-09-12 | Hashad Mohamed Wa'el Ahmed Chief Executive Officer | Option exercise · Subscription Rights (right to buy) | −10,000 | 95,905 | ||
| 2023-09-12 | Hashad Mohamed Wa'el Ahmed Chief Executive Officer | Sale · Subscription Rights (right to buy) | −100 | $0.02 | $2 | 95,805 |
| 2023-09-12 | Hashad Mohamed Wa'el Ahmed Chief Executive Officer | Sale · Subscription Rights (right to buy) | −100 | $0.02 | $2 | 95,705 |
| 2023-09-12 | Hashad Mohamed Wa'el Ahmed Chief Executive Officer | Sale · Subscription Rights (right to buy) | −253 | $0.02 | $4 | 95,452 |
| 2023-09-12 | Hashad Mohamed Wa'el Ahmed Chief Executive Officer | Sale · Subscription Rights (right to buy) | −400 | $0.02 | $8 | 95,052 |
| 2023-09-12 | Hashad Mohamed Wa'el Ahmed Chief Executive Officer | Sale · Subscription Rights (right to buy) | −2,852 | $0.02 | $47 | 92,200 |
| 2023-09-12 | Hashad Mohamed Wa'el Ahmed Chief Executive Officer | Sale · Subscription Rights (right to buy) | −3,000 | $0.02 | $48 | 89,200 |
| 2023-09-12 | Hashad Mohamed Wa'el Ahmed Chief Executive Officer | Sale · Subscription Rights (right to buy) | −6,700 | $0.02 | $109 | 82,500 |
| 2023-09-08 | Hare Joshua Chief Scientific Officer | Sale · Subscription Rights (right to buy) | −50,000 | $0.02 | $885 | 39,226,771 |
| 2023-09-08 | Soffer Rock Director | Option exercise | +30,000 | $3.00 | $90K | 702,351 |
| 2023-09-08 | Soffer Rock Director | Option exercise · Subscription Rights (right to buy) | −30,000 | 3,329,255 | ||
| 2023-09-07 | Hare Joshua Chief Scientific Officer | Sale · Subscription Rights (right to buy) | −15,400 | $0.02 | $370 | 39,276,771 |
| 2023-09-06 | Hare Joshua Chief Scientific Officer | Sale · Subscription Rights (right to buy) | −17,700 | $0.03 | $453 | 39,292,171 |
Page 9 of 14 · 271 trades